Navigation Links
FDA Approves Adcetris to Treat Two Types of Lymphoma
Date:8/19/2011

SILVER SPRING, Md., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Lymphomas are cancers of the lymphatic system. Adcetris is an antibody-drug conjugate that combines an antibody and drug, allowing the antibody to direct the drug to a target on lymphoma cells known as CD30.

Adcetris is to be used in patients with HL whose disease has progressed after autologous stem cell transplant or after two prior chemotherapy treatments for those who cannot receive a transplant. Autologous stem cell transplant is a procedure using a patient's own bone marrow that is designed to repair damaged bone marrow after the use of high chemotherapy doses. Adcetris may also be used in patients with ALCL whose disease has progressed after one prior chemotherapy treatment.

"Early clinical data suggest that patients who received Adcetris for Hodgkin lymphoma and systemic anaplastic lymphoma experienced a significant response to the therapy," said Richard Pazdur, M.D., director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research.

According to the National Cancer Institute (NCI), common symptoms of HL include the enlargement of lymph nodes, spleen, fever, weight loss, fatigue, or night sweats. NCI estimates that 8,830 new cases of HL will be diagnosed in the United States in 2011 and about 1,300 people will die from the disease.

Systemic ALCL is a rare malignant tumor (non-Hodgkin lymphoma) that may appear in several parts of the body including the lymph nodes, skin, bones, soft tissue, lungs or liver, according to the NCI.

Adcetris is the first new FDA-approved treatment for HL since 1977 and the first specifically indicated to treat ALCL.

The effective
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... og BERKELEY, California ... CMC Biologics, Inc. , som er af de ... produktion af terapeutiske proteiner, meddelte i dag, at ... af den globale produktionskapacitet, udvider produktionskapaciteten på fabrikken ... Logo -  http://photos.prnewswire.com/prnh/20110502/SF93356LOGO Kunderne får ...
(Date:5/21/2015)... 21, 2015 Thirteen winners of the ... to bring promising medical inventions to market, were ... in collaboration with the National Institutes of Health ... The winning teams were selected based on their ... will move forward to phase three of the ...
(Date:5/21/2015)... , May 21, 2015  AbbVie (NYSE: ABBV ... pursuant to its previously announced offer to acquire each ... for a mix of cash and AbbVie common stock, ... filed with the Securities and Exchange Commission by AbbVie ... assumption that the exchange offer will expire at 5:00 ...
Breaking Medicine Technology:CMC Biologics udvider GMP-produktionskapacitet i Europa 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 3Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 4AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4
(Date:5/22/2015)... May 22, 2015 A new program ... experts in the field of Physical Therapy. , ... takes the mystery out of physical therapy and discusses ... of motion for a variety of ailments and injuries. ... a personalized exercise plan that enhances daily activities such ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The House ... calling on religious leaders to make changes in order to ... his blog, discusses the history of war, how it started, ... Yisrayl says mankind was created to lead peaceful, joyful lives, ... , “Yahweh created mankind, according to His Plan, which ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... distributor of patented products, launches the Troll Motor Guide, ... convenient way of boating. , "The recreational boating industry ... Scott J. Cooper, CEO and Creative Director of ... water in record numbers and predicts continued steady growth ...
(Date:5/21/2015)... Md. (PRWEB) May 21, 2015 The ... the University of Maryland, Baltimore Commercial Advisory Board has ... Maryland Health Care System as one of two $50,000 ... their ankle robot research, known as Anklebot. Developed ... Excellence, in collaboration with the University of Maryland School ...
(Date:5/21/2015)... 2015 Bird B Gone, the leader in ... added new sizes of the Bird Spike 2001 to its ... steel bird spike is specifically designed to reduce building ... roof lines, parapet walls, I-beams, window ledges and more. It ... foot boxes, allowing customers to buy the right amount of ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3
... 3 VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ... minimally invasive treatment of venous reflux disease, today,announced ... President of,Research & Development., Mr. Kamdar joins ... in the medical device industry. Most recently, he ...
... AIDS epidemic update released last week has revised the global ... the estimate for India to 2.5 million people living with ... estimate of 5.7 million people. This revision is based on ... India. , A commentary published in the Lancet on World ...
... hinder the brains ability to recover from injury, a ... implications for the effects of environmental lead exposure on ... Medical College, who led the work. , Lead exposure ... for cancer, renal disease, hypertension and cardiovascular disease later ...
... more households and more drain on resources, study suggests ... only makes the world go round, it may make it ... are living in each household, causing them to take up ... study suggests. , "People talk about divorce hurting the children. ...
... Psychiatry researchers at Washington University School of Medicine in St. ... in young adults is associated with having a high number ... 50 or 100 partners, and research shows and common ... have, the more likely you,ll encounter someone with an STD," ...
... ICx,Technologies (Nasdaq: ICXT ), a developer of ... today a research,study with Merck & Co., Inc. and ... of the study is to test and refine a ... from blood -- a key,early detector for cancer treatment ...
Cached Medicine News:Health News:VNUS Medical Technologies Appoints Kirti Kamdar as Senior Vice President of Research & Development 2Health News:Implications of the new HIV estimate for India 2Health News:Jefferson neuroscientists find early lead exposure impedes recovery from brain injury 2Health News:Divorce Isn't Eco-Friendly 2Health News:Divorce Isn't Eco-Friendly 3Health News:Heavy drinking, conduct disorder linked to high-risk sexual behavior 2Health News:Heavy drinking, conduct disorder linked to high-risk sexual behavior 3Health News:ICx Technologies Works With Merck & Co., Inc. to Develop Cancer Diagnostic Technology 2
... Peg electrodes typically are positioned ... enable epidural recording of brain ... and are furnished in several ... thicknesses. A 4.6 mm twist ...
... cortical strip electrodes are extra thin ... through a burr hole. The narrow ... enables quick and secure attachment to ... Integra Epilepsy electrode designs, they are ...
... John R. Gates and Mary E. Dunn ... are designed for reliability, safety and ease ... electrodes, platinum contacts are mounted flush with ... have larger exposures. Strip and depth electrodes ...
Integra Epilepsy grid electrodes are thin and flexible for easier placement and to conform to the curvature of the cortical surface. Lead tunneling is done using a 14-gauge tunneling needle (ET-2)....
Medicine Products: